Cargando…
Lipid Nanoparticles: Promising Treatment Approach for Parkinson’s Disease
Parkinson’s disease (PD), a neurodegenerative disorder, is a life-altering, debilitating disease exhibiting a severe physical, psychological, and financial burden on patients. Globally, approximately 7–10 million people are afflicted with this disease, with the number of cases estimated to increase...
Autores principales: | Jagaran, Keelan, Singh, Moganavelli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408920/ https://www.ncbi.nlm.nih.gov/pubmed/36012619 http://dx.doi.org/10.3390/ijms23169361 |
Ejemplares similares
-
Nanomedicine for Neurodegenerative Disorders: Focus on Alzheimer’s and Parkinson’s Diseases
por: Jagaran, Keelan, et al.
Publicado: (2021) -
Copolymer-Green-Synthesized Copper Oxide Nanoparticles Enhance Folate-Targeting in Cervical Cancer Cells In Vitro
por: Jagaran, Keelan, et al.
Publicado: (2023) -
The Potential of Curcumin-Capped Nanoparticle Synthesis in Cancer Therapy: A Green Synthesis Approach
por: Venkatas, Jeaneen, et al.
Publicado: (2022) -
Recent Advances in Lipid-Based Nanosystems for Gemcitabine and Gemcitabine–Combination Therapy
por: Habib, Saffiya, et al.
Publicado: (2021) -
Current Stimuli-Responsive Mesoporous Silica Nanoparticles for Cancer Therapy
por: Moodley, Thashini, et al.
Publicado: (2021)